PMID- 37076800 OWN - NLM STAT- MEDLINE DCOM- 20230421 LR - 20230422 IS - 1471-2377 (Electronic) IS - 1471-2377 (Linking) VI - 23 IP - 1 DP - 2023 Apr 19 TI - Cerebral venous thrombosis with hyperhomocysteinemia due to loss of heterozygosity at methylenetetrahydrofolate reductase (MTHFR) locus: a case report. PG - 154 LID - 10.1186/s12883-023-03200-y [doi] LID - 154 AB - BACKGROUND: Loss of heterozygosity (LOH) at methylenetetrahydrofolate reductase (MTHFR) locus has been reported in tumor tissue. But the mutation was never reported in cerebral venous thrombosis (CVT) with hyperhomocysteinemia (HHcy) before. CASE PRESENTATION: A 14-year-old girl was admitted with an intermittent headache and nausea for 2 months. The plasma homocysteine level was 77.2 micromol/L. Lumbar puncture revealed an intracranial pressure > 330 mmH2O. Cerebral MRI and MRV revealed superior sagittal sinus thrombosis. Whole-exome sequencing revealed LOH at Chr1:11836597-11,867,232 affects exons 10-21 of C1orf167, the entire MTHFR, and exons 1-2 of the CLCN6 gene. The normal allele was the c.665 C > T/677 C > T variant in MTHFR. The patient was treated with nadroparin for 2 weeks, followed by oral rivaroxaban. Supplemental folate and vitamins B12 and B6 were prescribed. One month later, she had no headache and the intracranial pressure had decreased to 215 mmH2O. MRI showed shrinkage of the thrombosis in the superior sagittal sinus, the degree of stenosis had significantly decreased. CONCLUSIONS: Rare LOH at the MTHFR locus should be analyzed in CVT with HHcy. With anticoagulation treatment, the prognosis was good. CI - (c) 2023. The Author(s). FAU - Zhang, Mingjie AU - Zhang M AD - Department of Neurology, The First Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, PR China. FAU - Shi, Bingxin AU - Shi B AD - Brain Science Center, Tsinghua University Yuquan Hospital, No. 5 Shijingshan Road, Beijing, 100049, PR China. FAU - Zhao, Mangsuo AU - Zhao M AUID- ORCID: 0000-0001-8648-9166 AD - Brain Science Center, Tsinghua University Yuquan Hospital, No. 5 Shijingshan Road, Beijing, 100049, PR China. zhaomangsuo@163.com. LA - eng GR - 10001020116/Tsinghua Precision Medicine Foundation/ PT - Case Reports PT - Journal Article DEP - 20230419 PL - England TA - BMC Neurol JT - BMC neurology JID - 100968555 RN - EC 1.5.1.20 (Methylenetetrahydrofolate Reductase (NADPH2)) RN - 935E97BOY8 (Folic Acid) RN - 0LVT1QZ0BA (Homocysteine) RN - EC 1.5.1.20 (MTHFR protein, human) SB - IM MH - Female MH - Humans MH - Adolescent MH - Methylenetetrahydrofolate Reductase (NADPH2)/genetics MH - *Hyperhomocysteinemia/complications/genetics MH - Heterozygote MH - *Intracranial Thrombosis/complications MH - Folic Acid MH - *Venous Thrombosis/complications/diagnostic imaging/drug therapy MH - Loss of Heterozygosity MH - Homocysteine MH - Genotype PMC - PMC10114475 OTO - NOTNLM OT - Cerebral venous thrombosis OT - Hyperhomocysteinemia OT - Loss of heterozygosity OT - Methylenetetrahydrofolate reductase COIS- The authors have nothing to disclose. EDAT- 2023/04/20 00:41 MHDA- 2023/04/21 06:41 PMCR- 2023/04/19 CRDT- 2023/04/19 23:53 PHST- 2022/07/27 00:00 [received] PHST- 2023/04/04 00:00 [accepted] PHST- 2023/04/21 06:41 [medline] PHST- 2023/04/20 00:41 [pubmed] PHST- 2023/04/19 23:53 [entrez] PHST- 2023/04/19 00:00 [pmc-release] AID - 10.1186/s12883-023-03200-y [pii] AID - 3200 [pii] AID - 10.1186/s12883-023-03200-y [doi] PST - epublish SO - BMC Neurol. 2023 Apr 19;23(1):154. doi: 10.1186/s12883-023-03200-y.